Cross-Sector entity
Andrew Beale is most often covered alongside Arete Research, which appears in 5 of these 5 stories. Across a 13-day span, the pace is roughly 2.7 stories per week. The busiest single day carried 3. ipo accounts for 2 of the 5 tracked stories, while 3 other categories carry the remainder.
5 verified stories tracked
Last mentioned: Jul 3, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 40 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Andrew Beale is most often covered alongside Arete Research, which appears in 5 of these 5 stories. Across a 13-day span, the pace is roughly 2.7 stories per week. The busiest single day carried 3. ipo accounts for 2 of the 5 tracked stories, while 3 other categories carry the remainder. Negative sentiment appears in 0% of the tracked stories. Andrew Beale appears in 5 tracked Cross-Sector stories published from June 21, 2026 through July 3, 2026. Each carries 3 original sources on average.
Computed from the 5 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Andrew Beale. Shared-story counts are live from our verified record — not editorial picks.
SpaceX’s record $85.7 billion IPO, backed by an unprecedented 23-bank syndicate, faces a new chapter as analyst coverage unlocks July 7. For the startup ecosystem, this is a bellwether for late-stage valuations and the appetite for complex tech IPOs.
With the IPO quiet period expiring on July 7, SpaceX will finally get analyst ratings just as Starship and StarlinkV3 move toward deployment. The most bullish call sees $401. For aerospace investors, the impending coverage wave will clarify whether the market is properly valuing the company’s next-generation space and satellite assets.
The July 7 expiration of the quiet period for 23 underwriters will flood the market with SpaceX research, likely driving significant SPCX volatility. With a $401 price target already out, investors must weigh the risk of sharp price swings against the long-term growth story.
Source: The Motley Fool · CPA (us)
A veteran telecom analyst just slapped a $401 price target on SpaceX, implying a $5.3 trillion valuation and 117% upside. Such a call demands investors accept 80x forward sales and the uncertainty of an unproven rocket.
Arete Research’s $401 price target for SpaceX isn’t just a financial call—it’s a wager on Starship achieving commercial viability. Without that heavy-lift rocket, the Starlink V3 satellites that form the analyst’s thesis remain grounded, leaving the stock’s upside highly uncertain.
Source: Miamiherald · Kansascity
